HealthEquity, Inc. $HQY Shares Sold by Advantage Alpha Capital Partners LP

Advantage Alpha Capital Partners LP reduced its stake in shares of HealthEquity, Inc. (NASDAQ:HQY) by 27.8% during the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 44,714 shares of the company’s stock after selling 17,202 shares during the period. HealthEquity makes up about 1.3% of Advantage Alpha Capital Partners LP’s holdings, making the stock its 23rd largest position. Advantage Alpha Capital Partners LP owned about 0.05% of HealthEquity worth $4,684,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Farther Finance Advisors LLC boosted its holdings in HealthEquity by 232.4% during the second quarter. Farther Finance Advisors LLC now owns 246 shares of the company’s stock worth $26,000 after buying an additional 172 shares in the last quarter. Caitong International Asset Management Co. Ltd purchased a new position in HealthEquity in the second quarter valued at about $33,000. WPG Advisers LLC acquired a new stake in shares of HealthEquity during the 1st quarter valued at approximately $28,000. Cullen Frost Bankers Inc. boosted its stake in shares of HealthEquity by 172.3% during the 2nd quarter. Cullen Frost Bankers Inc. now owns 354 shares of the company’s stock worth $37,000 after acquiring an additional 224 shares in the last quarter. Finally, Sellwood Investment Partners LLC acquired a new stake in shares of HealthEquity in the 2nd quarter worth approximately $58,000. 99.55% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research firms recently weighed in on HQY. Jefferies Financial Group raised their price objective on HealthEquity from $130.00 to $134.00 and gave the company a “buy” rating in a research note on Wednesday, September 3rd. Weiss Ratings restated a “hold (c+)” rating on shares of HealthEquity in a research report on Wednesday, October 8th. Royal Bank Of Canada lifted their price target on HealthEquity from $109.00 to $110.00 and gave the stock an “outperform” rating in a research note on Wednesday, September 3rd. JPMorgan Chase & Co. boosted their price objective on shares of HealthEquity from $125.00 to $126.00 and gave the stock an “overweight” rating in a research report on Wednesday, September 3rd. Finally, KeyCorp dropped their target price on shares of HealthEquity from $125.00 to $120.00 and set an “overweight” rating for the company in a report on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and three have given a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $119.00.

HealthEquity Stock Performance

NASDAQ:HQY opened at $104.99 on Friday. The company has a market cap of $9.05 billion, a P/E ratio of 63.63, a P/E/G ratio of 1.36 and a beta of 0.47. The firm’s 50 day moving average is $95.89 and its two-hundred day moving average is $96.78. HealthEquity, Inc. has a fifty-two week low of $74.07 and a fifty-two week high of $116.65. The company has a quick ratio of 4.23, a current ratio of 4.23 and a debt-to-equity ratio of 0.47.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings data on Tuesday, September 2nd. The company reported $0.92 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.92. The company had revenue of $325.80 million during the quarter, compared to analysts’ expectations of $320.68 million. HealthEquity had a net margin of 11.49% and a return on equity of 12.04%. HealthEquity has set its FY 2026 guidance at 3.740-3.91 EPS. Analysts expect that HealthEquity, Inc. will post 2.32 EPS for the current year.

Insider Activity

In other news, EVP Delano Ladd sold 1,500 shares of the business’s stock in a transaction dated Thursday, November 20th. The stock was sold at an average price of $104.56, for a total transaction of $156,840.00. Following the completion of the sale, the executive vice president owned 75,479 shares in the company, valued at approximately $7,892,084.24. The trade was a 1.95% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Michael Henry Fiore sold 1,781 shares of the business’s stock in a transaction dated Tuesday, October 7th. The stock was sold at an average price of $88.21, for a total value of $157,102.01. Following the sale, the executive vice president owned 49,795 shares of the company’s stock, valued at $4,392,416.95. The trade was a 3.45% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 10,781 shares of company stock valued at $1,016,707 over the last 90 days. 1.50% of the stock is currently owned by insiders.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.